Details of the Drug Reposition

General Information of This Drug (ID: DMDWYUN)

Drug Name
HBI-8000   DMDWYUN
Synonyms CS055; SCHEMBL5500152; GTPL8305; AKOS026750315; N-(2-amino-5-fluorophenyl)-4-{[3-(pyridin-3-yl)prop-2-enamido]methyl}benzamide
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Registered Indication(s)
Indication Name Indication ID ICD-11 Status REF
Solid tumour/cancer DISZR48F 2A00-2F9Z Registered [1]
Non-small-cell lung cancer DIS5Y6R9 2C25.Y Registered [2]
------------------------------------------------------------------------------------
3 Phase 1/2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Melanoma DIS1RRCY 2C30 Phase 1/2 [2]
Merkel cell carcinoma DISDJJ4U 2C34 Phase 1/2 [2]
Renal cell carcinoma DISQZ2X8 2C90 Phase 1/2 [2]
------------------------------------------------------------------------------------

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8305).
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)